After completing this activity, pharmacists should be able to:
1.describe the prevalence of schizophrenia in Australia and overseas including the incidence relating to age and gender
2.list the symptoms that occur in schizophrenics and the tools for the diagnosis of schizophrenia
3. describe the pharmacological treatments recommended for schizophrenia, their efficacy and their range of adverse effects
4. describe the way in which pharmacists can help patients suffering with schizophrenia
The 2016 Competency Standards addressed by this activity include: 2.1, 2.3, 3.1, 3.2, 3.5, 3.6
Accreditation number: A1902RP1 Accreditation expires: 01/02/2021
This activity has been accredited for 1.0 hour of Group One CPD (or 1.0 CPD credit) suitable for inclusion in an individual pharmacist’s CPD plan, which may be converted to 1.0 hour of Group Two CPD (or 2.0 CPD credits) upon successful completion of the associated assessment activity.